Brought to you by 
Medarex, investors, found Danish biotech Genmab
13 Jul 1999
Executive Summary
Medarex (monoclonal antibodies), along with investors BankInvest Biomedical, AS Dansk Erhvervinvestering, and others, have set up a Danish company to develop and market human antibodies based on Medarex's HuMAb mouse technology.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
-
Large Molecule
- Antibodies
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medarex, investors, found Danish biotech Genmab
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice